Literature DB >> 20725799

Intra-abdominal fat predicts survival in pancreatic cancer.

Courtney J Balentine1, Jose Enriquez, William Fisher, Sally Hodges, Vivek Bansal, Shubhada Sansgiry, Nancy J Petersen, David H Berger.   

Abstract

BACKGROUND: Body mass index (BMI) has proven unreliable in predicting survival following pancreaticoduodenectomy for cancer. While measures of intra-abdominal fat correlate with medical and postoperative complications of obesity, the impact of intra-abdominal fat on pancreatic cancer survival is uncertain. We hypothesized that the quantity of intra-abdominal fat would predict survival following resection of pancreatic cancer.
METHODS: Preoperative CT imaging was used to measure intra-abdominal fat. Cox regression analyses were used to identify independent predictors of survival.
RESULTS: Sixty-one patients from 2000-2009 underwent pancreaticoduodenectomy for exocrine pancreatic adenocarcinoma. After adjusting for age and perineural invasion status, preoperative BMI did not predict overall survival (p < 0.827). Unlike BMI, quartile of intra-abdominal fat predicted survival. Relative to patients with the least intra-abdominal fat (lowest quartile), those with more intra-abdominal fat demonstrated worse overall survival, but in a non-linear fashion. Individuals in the second quartile showed a fourfold increase in likelihood of death (HR 4.018, 95% CI 1.099-14.687, p < 0.035) relative to the lowest quartile. Patients in the third (HR 2.124, 95% CI 0.278-16.222, p < 0.468) and fourth quartile (HR 1.354, 95% CI 0.296-6.190, p < 0.696) also showed greater risk of death.
CONCLUSIONS: Measuring intra-abdominal fat identifies a subset of patients with worse prognosis in pancreatic cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20725799     DOI: 10.1007/s11605-010-1297-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  19 in total

1.  Impact of visceral obesity on surgical outcome after laparoscopic surgery for rectal cancer.

Authors:  Y Ishii; H Hasegawa; H Nishibori; M Watanabe; M Kitajima
Journal:  Br J Surg       Date:  2005-10       Impact factor: 6.939

2.  Evaluation of the technical difficulty performing laparoscopic resection of a rectosigmoid carcinoma: visceral fat reflects technical difficulty more accurately than body mass index.

Authors:  Y Seki; M Ohue; M Sekimoto; S Takiguchi; I Takemasa; M Ikeda; H Yamamoto; M Monden
Journal:  Surg Endosc       Date:  2007-02-07       Impact factor: 4.584

3.  Annual medical spending attributable to obesity: payer-and service-specific estimates.

Authors:  Eric A Finkelstein; Justin G Trogdon; Joel W Cohen; William Dietz
Journal:  Health Aff (Millwood)       Date:  2009-07-27       Impact factor: 6.301

4.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

5.  Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma.

Authors:  Jason B Fleming; Ricardo J Gonzalez; Maria Q B Petzel; E Lin; Jeffrey S Morris; Henry Gomez; Jeffrey E Lee; Christopher H Crane; Peter W T Pisters; Douglas B Evans
Journal:  Arch Surg       Date:  2009-03

Review 6.  The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

Authors:  Edward Giovannucci; Dominique Michaud
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

7.  Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution.

Authors:  Michael G House; Yuman Fong; Dean J Arnaoutakis; Rohit Sharma; Corinne B Winston; Mladjan Protic; Mithat Gonen; Sara H Olson; Robert C Kurtz; Murray F Brennan; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2007-12-01       Impact factor: 3.452

8.  Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy.

Authors:  Timothy K Williams; Ernest L Rosato; Eugene P Kennedy; Karen A Chojnacki; Jocelyn Andrel; Terry Hyslop; Cataldo Doria; Patricia K Sauter; Jordan Bloom; Charles J Yeo; Adam C Berger
Journal:  J Am Coll Surg       Date:  2008-12-18       Impact factor: 6.113

9.  The impact of obesity on surgical outcome after pancreaticoduodenectomy.

Authors:  Roger Noun; Edward Riachy; Claude Ghorra; Thierry Yazbeck; Cyril Tohme; Bassam Abboud; Samah Naderi; Viviane Chalhoub; Eliane Ayoub; Patricia Yazbeck
Journal:  JOP       Date:  2008-07-10

10.  The impact of obesity on outcomes following pancreatectomy for malignancy.

Authors:  Matthew Benns; Charles Woodall; Charles Scoggins; Kelly McMasters; Robert Martin
Journal:  Ann Surg Oncol       Date:  2009-06-26       Impact factor: 5.344

View more
  28 in total

Review 1.  Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms.

Authors:  Paige M Bracci
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors.

Authors:  Ann H Klopp; Yan Zhang; Travis Solley; Felipe Amaya-Manzanares; Frank Marini; Michael Andreeff; Bisrat Debeb; Wendy Woodward; Rosemarie Schmandt; Russell Broaddus; Karen Lu; Mikhail G Kolonin
Journal:  Clin Cancer Res       Date:  2011-12-13       Impact factor: 12.531

Review 3.  The Obesity Paradox in Cancer-Moving Beyond BMI.

Authors:  Shlomit Strulov Shachar; Grant R Williams
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-01       Impact factor: 4.254

Review 4.  The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: a systematic review.

Authors:  D J Gibson; S T Burden; B J Strauss; C Todd; S Lal
Journal:  Eur J Clin Nutr       Date:  2015-03-18       Impact factor: 4.016

5.  Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma.

Authors:  Roy Mano; A Ari Hakimi; Emily C Zabor; Marta A Bury; Olivio F Donati; Christoph A Karlo; Wassim M Bazzi; Helena Furberg; Paul Russo
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

Review 6.  Premorbid Obesity and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis.

Authors:  Kaustav Majumder; Arjun Gupta; Nivedita Arora; Preet Paul Singh; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-14       Impact factor: 11.382

7.  Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey.

Authors:  Chao-Feng Chang; Yu-Chen Tseng; Hsin-Hung Huang; Yu-Lueng Shih; Tsai-Yuan Hsieh; Hsuan-Hwai Lin
Journal:  Intern Emerg Med       Date:  2017-12-12       Impact factor: 3.397

8.  Spontaneous formation of tumorigenic hybrids between human omental adipose-derived stromal cells and endometrial cancer cells increased motility and heterogeneity of cancer cells.

Authors:  Mingxia Li; Xiaoping Li; Lijun Zhao; Jingyi Zhou; Yuan Cheng; Bo Xu; Jianliu Wang; Lihui Wei
Journal:  Cell Cycle       Date:  2019-01-22       Impact factor: 4.534

9.  Impact of Visceral Obesity and Sarcopenia on Short-Term Outcomes After Colorectal Cancer Surgery.

Authors:  Wei-Zhe Chen; Xiao-Dong Chen; Liang-Liang Ma; Feng-Min Zhang; Ji Lin; Cheng-Le Zhuang; Zhen Yu; Xiao-Lei Chen; Xiao-Xi Chen
Journal:  Dig Dis Sci       Date:  2018-03-16       Impact factor: 3.199

10.  Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.

Authors:  Dietmar Tamandl; Matthias Paireder; Reza Asari; Pascal A Baltzer; Sebastian F Schoppmann; Ahmed Ba-Ssalamah
Journal:  Eur Radiol       Date:  2015-09-03       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.